Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics

C Steiner, S Arnould, A Scalbert… - British Journal of Nutrition, 2008 - cambridge.org
Epidemiological evidence together with preclinical data from animal and in vitro studies
strongly support a correlation between soy isoflavone consumption and protection towards …

mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer

G Lanza, M Ferracin, R Gafà, A Veronese, R Spizzo… - Molecular cancer, 2007 - Springer
Background Colorectal cancer develops through two main genetic instability pathways
characterized by distinct pathologic features and clinical outcome. Results We investigated …

Proteomics in 2005/2006: developments, applications and challenges

JC Smith, JP Lambert, F Elisma, D Figeys - Analytical chemistry, 2007 - ACS Publications
The field of proteomics has continually evolved as our global understanding of cellular and
biochemical systems has matured and as new research tools have been developed. Our …

VEGF elicits epithelial-mesenchymal transition (EMT) in prostate intraepithelial neoplasia (PIN)-like cells via an autocrine loop

O Gonzalez-Moreno, J Lecanda, JE Green… - Experimental cell …, 2010 - Elsevier
Vascular endothelial growth factor (VEGF) is overexpressed during the transition from
prostate intraepithelial neoplasia (PIN) to invasive carcinoma. We have mimicked such a …

Lycopene modulates growth and survival associated genes in prostate cancer

MM Rafi, S Kanakasabai, MD Reyes… - The Journal of nutritional …, 2013 - Elsevier
Lycopene is a fat soluble red-orange carotenoid pigment present in tomato that reduces the
risk for prostate cancer, a common malignancy among men. However, the mechanism by …

Gene expression assays

J Kirby, PR Heath, PJ Shaw, FC Hamdy - Advances in clinical chemistry, 2007 - Elsevier
The study of the profile of gene expression in a cell or tissue at a particular moment gives an
insight into the plans of the cell for protein synthesis. Recent technological advances make it …

Overexpression of CD24, c-myc and Phospholipase 2A in Prostate Cancer Tissue Samples Obtained by Needle Biopsy

B Nagy, A Szendroi, I Romics - Pathology & Oncology Research, 2009 - Springer
Altered CD24, c-myc and phospholipase 2a expression was reported in different cancers.
Our aim was to measure the expression of these genes in prostate cancer tissues, and …

Genomics of prostate cancer: Is there anything to „translate”?

L Kopper, J Tímár - Pathology & Oncology Research, 2005 - Springer
This review provides an up-dated collection of data concerning the genetic and epigenetic
changes during development, growth and progression of prostate cancer. Hereditary and …

Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer

M Schostak, H Krause, K Miller, M Schrader, S Weikert… - BMC urology, 2006 - Springer
Background Gene expression profiling has recently shown that the mRNA for CD24 is
overexpressed in prostate carcinomas (Pca) compared to benign or normal prostate …

Application of genomic technologies to human prostate cancer

S Li, S Bhamre, J Lapointe, JR Pollack… - OMICS: A Journal of …, 2006 - liebertpub.com
Prostate cancer is the most commonly diagnosed non-cutaneous malignancy in US males
and has a broad spectrum of clinical behavior ranging from indolent to lethal. Microarray …